French Guiana

Reimbursed Care Access

French Guiana, as an overseas department of France, is governed by French national drug and health law. Most classic psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, 2C‑X, ayahuasca, ibogaine) are classified as narcotics and have no authorised medical use outside approved clinical research; however, esketamine (Spravato) is an authorised, regulated medicinal product in metropolitan France and therefore applies in French Guiana under the same national regulatory and reimbursement processes. Ketamine (the racemate) is sometimes used off‑label in specialist settings for treatment‑resistant depression in Europe but is not a routine reimbursed pathway under French public health insurance outside established indications and protocols.